Global Artificial Pancreas Device System (APDS) Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1736

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
In 2018, the global Artificial Pancreas Device System (APDS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Artificial Pancreas Device System (APDS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Artificial Pancreas Device System (APDS) development in United States, Europe and China.

The key players covered in this study
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
...

Market segment by Type, the product can be split into
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Artificial Pancreas Device System (APDS) status, future forecast, growth opportunity, key market and key players.
To present the Artificial Pancreas Device System (APDS) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Artificial Pancreas Device System (APDS) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Artificial Pancreas Device System (APDS) Market Size Growth Rate by Type (2014-2025)
1.4.2 Threshold Suspended Device Systems
1.4.3 Hybrid Closed-loop APDS
1.4.4 Other Systems
1.5 Market by Application
1.5.1 Global Artificial Pancreas Device System (APDS) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Artificial Pancreas Device System (APDS) Market Size
2.2 Artificial Pancreas Device System (APDS) Growth Trends by Regions
2.2.1 Artificial Pancreas Device System (APDS) Market Size by Regions (2014-2025)
2.2.2 Artificial Pancreas Device System (APDS) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Artificial Pancreas Device System (APDS) Market Size by Manufacturers
3.1.1 Global Artificial Pancreas Device System (APDS) Revenue by Manufacturers (2014-2019)
3.1.2 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Artificial Pancreas Device System (APDS) Market Concentration Ratio (CR5 and HHI)
3.2 Artificial Pancreas Device System (APDS) Key Players Head office and Area Served
3.3 Key Players Artificial Pancreas Device System (APDS) Product/Solution/Service
3.4 Date of Enter into Artificial Pancreas Device System (APDS) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Artificial Pancreas Device System (APDS) Market Size by Type (2014-2019)
4.2 Global Artificial Pancreas Device System (APDS) Market Size by Application (2014-2019)

5 United States
5.1 United States Artificial Pancreas Device System (APDS) Market Size (2014-2019)
5.2 Artificial Pancreas Device System (APDS) Key Players in United States
5.3 United States Artificial Pancreas Device System (APDS) Market Size by Type
5.4 United States Artificial Pancreas Device System (APDS) Market Size by Application

6 Europe
6.1 Europe Artificial Pancreas Device System (APDS) Market Size (2014-2019)
6.2 Artificial Pancreas Device System (APDS) Key Players in Europe
6.3 Europe Artificial Pancreas Device System (APDS) Market Size by Type
6.4 Europe Artificial Pancreas Device System (APDS) Market Size by Application

7 China
7.1 China Artificial Pancreas Device System (APDS) Market Size (2014-2019)
7.2 Artificial Pancreas Device System (APDS) Key Players in China
7.3 China Artificial Pancreas Device System (APDS) Market Size by Type
7.4 China Artificial Pancreas Device System (APDS) Market Size by Application

8 Japan
8.1 Japan Artificial Pancreas Device System (APDS) Market Size (2014-2019)
8.2 Artificial Pancreas Device System (APDS) Key Players in Japan
8.3 Japan Artificial Pancreas Device System (APDS) Market Size by Type
8.4 Japan Artificial Pancreas Device System (APDS) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Artificial Pancreas Device System (APDS) Market Size (2014-2019)
9.2 Artificial Pancreas Device System (APDS) Key Players in Southeast Asia
9.3 Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Type
9.4 Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Application

10 India
10.1 India Artificial Pancreas Device System (APDS) Market Size (2014-2019)
10.2 Artificial Pancreas Device System (APDS) Key Players in India
10.3 India Artificial Pancreas Device System (APDS) Market Size by Type
10.4 India Artificial Pancreas Device System (APDS) Market Size by Application

11 Central & South America
11.1 Central & South America Artificial Pancreas Device System (APDS) Market Size (2014-2019)
11.2 Artificial Pancreas Device System (APDS) Key Players in Central & South America
11.3 Central & South America Artificial Pancreas Device System (APDS) Market Size by Type
11.4 Central & South America Artificial Pancreas Device System (APDS) Market Size by Application

12 International Players Profiles
12.1 Medtronic
12.1.1 Medtronic Company Details
12.1.2 Company Description and Business Overview
12.1.3 Artificial Pancreas Device System (APDS) Introduction
12.1.4 Medtronic Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.1.5 Medtronic Recent Development
12.2 Bigfoot Biomedical
12.2.1 Bigfoot Biomedical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Artificial Pancreas Device System (APDS) Introduction
12.2.4 Bigfoot Biomedical Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.2.5 Bigfoot Biomedical Recent Development
12.3 Beta Bionics
12.3.1 Beta Bionics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Artificial Pancreas Device System (APDS) Introduction
12.3.4 Beta Bionics Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.3.5 Beta Bionics Recent Development
12.4 Admetsys
12.4.1 Admetsys Company Details
12.4.2 Company Description and Business Overview
12.4.3 Artificial Pancreas Device System (APDS) Introduction
12.4.4 Admetsys Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.4.5 Admetsys Recent Development
12.5 Insulet
12.5.1 Insulet Company Details
12.5.2 Company Description and Business Overview
12.5.3 Artificial Pancreas Device System (APDS) Introduction
12.5.4 Insulet Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.5.5 Insulet Recent Development
12.6 Tandem Diabetes Care
12.6.1 Tandem Diabetes Care Company Details
12.6.2 Company Description and Business Overview
12.6.3 Artificial Pancreas Device System (APDS) Introduction
12.6.4 Tandem Diabetes Care Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.6.5 Tandem Diabetes Care Recent Development
12.7 Defymed
12.7.1 Defymed Company Details
12.7.2 Company Description and Business Overview
12.7.3 Artificial Pancreas Device System (APDS) Introduction
12.7.4 Defymed Revenue in Artificial Pancreas Device System (APDS) Business (2014-2019)
12.7.5 Defymed Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details